Methodology to evaluate value chains, beta-lactam antibiotics case study
DOI:
https://doi.org/10.5281/zenodo.5512617Keywords:
value chain, antibiotics, beta-lactam, innovationAbstract
The idea of value chain is a systemic approach that has evolved upward, its application in the highly globalized Pharmaceutical Industry has allowed its reorganization at the international level. The target of the paper was to apply a methodology that would allow evaluating the value chain of beta-lactam antibiotics. For its development, different methodologies used in various sectors were analyzed, and its state of the art in the generic drugs sector was evaluated. When carrying out the analysis of the value chain of this family of antibiotics, its disarticulation was identified as not all the actors in the links of the chain were involved; the need to innovate differently was demonstrated through developing organizational and process innovations while still taking into account the latent risk of antimicrobial resistance.
Downloads
References
Backer K D, Miroudat S. Mapping Global Value Chains. Publishing. OECD [Internet]. 2013;159. [consultado 9 May 2021]; Disponible en: http://dx.doi.org/10.1787/5k3v1trgnbr4-en.
Sandoval S. La cadena global de valor: consideraciones desde el ciclo del capital. Problemas del Desarrollo [Internet]. 2015;46(182): 165-190. [consultado 11 Mar 2020]; Disponible en: https://www.sciencedirect.com/science/article/pii/S0301703615000279.
Brennan L, Rakhmatullin R. Global Value Chains and Smart Specialization Strategy. JRC Science for Policy Report [Internet]. 2015; ISBN 978-92-79-5481-0. [consultado 11 May 2021]; Disponible en: https://s3platform.jrc.ec.europa.eu/documents/20182/96243/Global+Value+Chains+and+Smart+Specialisation+Strategy/8546d7e1-0219-4ed4-905a-e637731d4846.
Kaplinsky R, Morris M. Un manual para investigación de cadena de valor. Ambiente y Diseño Industrial. Kaplinsky y Manual completo. [Internet]. 2000 [actualizado Abr 2010]. [consultado 11 May 2021]; Disponible en: https://www.scribd.com/document/306838008/Kaplinsky-Manual-Completo-Rev-4-2010doc.
Humphrey J, Schmitz H. Governance and upgrading: linking Industrial clusters and Global Value Chain Research, Institute of Development Studies [Internet]. 2000. IDS Working Paper 120. [consultado 13 May 2021]; Disponible en: https://www.ids.ac.uk/files/Wp120.pdf.
Dussel E. Cadenas globales de valor. Metodología, teoría y debates. [Internet]. 1ra ed. Universidad Nacional Autónoma de México;2018. [consultado 14 May 2021]; Disponible en: https://www3.eco.unicamp.br/neit/images/destaque/Cadenas_Globales_de_Valor_metodologia_teoria_y_debates.pdf.
Peña L. Inserción externa y crecimiento de la economía cubana: una mirada desde la econometría empírica. Economía y Desarrollo. [Internet]. 2018;159(1):97-118. [consultado 3 Mar 2019]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0252-85842018000100007&script=sci_abstract&tlng=es.
Peña L, Romero A, Molina E. Propuesta para la inserción de la economía cubana en la economía internacional. (Parte I). RCEI. [Internet]. 2016;2:1-27. [consultado 3 Mar 2021]; Disponible en: http://www.rcei.uh.cu/index.php/RCEI/article/view/60.
Aitken M. Understanding the pharmaceutical value chain. Pharmaceuticals Policy and Law [Internet]. 2016;18:55-66. [consultado 14 Abr 2019]; Disponible en: https://www.ifpma.org/wp-content/uploads/2016/11/6.-Understanding-the-Pharmaceutical-Value-Chain-1.pdf.
Antalóczy K, Gáspar T, Sass M. The specialities of the pharmaceutical value chains in Hungary. Acta Oeconomica [Internet]. 2019;69(S2):41-72. [consultado 14 Abr 2021]; Disponible en: http://real.mtak.hu/106474/1/032.2019.69.s2.3.pdf.
Chang-soo L, Mikyung Y. Accounting of gross exports and tracing foreign values in the global pharmaceutical value chain: Where does Korea stand? 2018; 22(4):10-15.
Reynolds E B, Zylberberg E, Campo M. Brazil’s Role in the Biopharmaceutical Global Value Chain. [Internet].MIT-IPC Working Paper 16-004. Accelerating Innovation in Brazil. 2016. [consultado 14 May 2021]; Disponible en: https://ipc.mit.edu/sites/default/files/2019-01/16-004.pdf.
Jurcal S, Sztulward S. La industria farmacéutica y el nuevo patrón de acumulación de la manufactura global. H-industria@ [Internet]. 2016;10(19). [consultado 13 Mar 2020]; Disponible en: http://www.lareferencia.info/vufind/Record/AR_3321cab8f423b51103cd4c440bafa11c.
Rodríguez A. Estudio cadena de valor en la industria farmacéutica Uruguay (Salud Humana). Serie de integración productiva regional. [Internet]. Working Paper 163;2013. [consultado 11 Feb 2021]; Disponible en: https://codigof.mx/wp-content/uploads/2017/02/EstudioCadenaValorIndustriaFarmaceuticaUruguay.pdf.
Sario N. Generics are climbing up. Generics Are Climbing up the Value Chain. [Internet]. Market realist. 2015 [actualizado 23 Mar; consultado 11 Feb 2021]; Disponible: https://marketrealist.com/2015/03/generics-climbing-value-chain/.
Belloso W. Historia de los antibióticos. Rev. Hosp. Ital. B.Aires [Internet]. 2009;29(2):102-111. [consultado 14 Mar 2021]; Disponible en: https://www1.hospitalitaliano.org.ar/multimedia/archivos/noticias_attachs/47/documentos/7482_102-111-belloso.pdf.
Simpkin V, Remvick M, Kelly R, Mossialos E. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. The Journal of Antibiotics [Internet]. 2017 [consultado 14 Abr 2021]; 70:1087-1096. Disponible en: https://www.nature.com/articles/ja2017124.pdf.
Lee R. Incentives and disincentives to drug innovation: evidence from recent literature. Journal of Medical Economics [Internet]. 2019 [consultado 14 Abr 2021]; 22(8): 713-714. Disponible en: https://www.tandfonline.com/doi/full/10.1080/13696998.2019.1613240
Zakic N, Bozilovic S, Sijakovic I. Analysis and upgrading OF value chain. ЕКОНОМИКА [Internet]. 2018 [consultado 30 Abr 2021]; 64(4): 1-15. Disponible en: https://www.ekonomika.org.rs/en/PDF/ekonomika/2018/Ekonomika-4-2018.pdf.
Festa G, Safraou I, Cuomo T, Solima L. Big data for big pharma: Harmonizing business process management to enhance ambidexterity. Business Process Management Journal. 2018; 24(5):13-16.
So A, Gupta N, Brahmachari S et al. Towards new business models for R&D for novel antibiotics. ELSEVIER [Internet]. 2011 [consultado 30 Mar 2021]; 14(2): 88-94. Disponible en: https://www.sciencedirect.com/science/article/pii/S1368764611000161.
Padilla R, Nahuel O. Manual para el fortalecimiento de cadenas de valor. Cepal [Internet]. Mexico; 2016 [consultado 14 Abr 2019]; Disponible en https://www.cepal.org/sites/default/files/publication/files/40662/S1601085_es.pdf.
Porter M, Kramer M. Estrategia y sociedad. Harvard Business Review. 2016; 84(12):42-56.
th Essential Medicines List (2017). [Internet]. 20th ed. World Health Organization; 2017. [consultado 12 Ene 2021]; Disponible en: https://www.who.int/medicines/news/2017/20th_essential_med-list/en/ .
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nancy Oña Aldama, Grisel Díaz Baigorría , Alejandro Saúl Padrón Yaquis , Xenia Madrazo Sagré
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
NonCommercial — You may not use the material for commercial purposes.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
scholar.google.com.cu
